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Abstract
Paradoxical sleep (PS) is a state characterized by cortical activation, rapid eye movements and muscle atonia. Fifty years after
its discovery, the neuronal network responsible for the genesis of PS has been only partially identified. We recently
proposed that GABAergic neurons would have a pivotal role in that network. To localize these GABAergic neurons, we
combined immunohistochemical detection of Fos with non-radioactive in situ hybridization of GAD67 mRNA (GABA
synthesis enzyme) in control rats, rats deprived of PS for 72 h and rats allowed to recover after such deprivation. Here we
show that GABAergic neurons gating PS (PS-off neurons) are principally located in the ventrolateral periaqueductal gray
(vlPAG) and the dorsal part of the deep mesencephalic reticular nucleus immediately ventral to it (dDpMe). Furthermore,
iontophoretic application of muscimol for 20 min in this area in head-restrained rats induced a strong and significant
increase in PS quantities compared to saline. In addition, we found a large number of GABAergic PS-on neurons in the
vlPAG/dDPMe region and the medullary reticular nuclei known to generate muscle atonia during PS. Finally, we showed
that PS-on neurons triggering PS localized in the SLD are not GABAergic. Altogether, our results indicate that multiple
populations of PS-on GABAergic neurons are distributed in the brainstem while only one population of PS-off GABAergic
neurons localized in the vlPAG/dDpMe region exist. From these results, we propose a revised model for PS control in which
GABAergic PS-on and PS-off neurons localized in the vlPAG/dDPMe region play leading roles.
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Introduction
Paradoxical sleep (PS) or REM sleep is characterized by cortical
activation, rapid eye movements and muscle atonia. We recently
showed in the rat that neurons generating PS are specifically active
during PS (PS-on or REM-on neurons) and localized in the
sublaterodorsal tegmental nucleus (SLD). We further demonstrat-
ed that the activation of these putative glutamatergic neurons is
gated by GABAergic neurons active during waking (W) and slow
wave sleep (SWS) (PS-off or REM-off neurons) [1]. Combining
retrograde tracing with cholera toxin B subunit (CTb) and
glutamate decarboxylase (GAD) immunostaining, we proposed
that these PS-off GABAergic neurons could be localized in three
areas namely the ventrolateral periaqueductal gray (vlPAG) and
the dorsal part of the deep mesencephalic reticular nucleus
(dDpMe), the caudal pontine reticular nucleus (PnC) and/or the
SLD itself [2]. In contrast, Maloney et al. [3] combining GAD67
and Fos immunohistochemistry proposed that the PS-off GA-
BAergic neurons are localized in the nucleus pontis oralis (PnO).
Finally, Lu et al. [4] showed that part of the SLD PS-on neurons
could be GABAergic combining GAD and Fos staining after PS
hypersomnia. They proposed that these GABAergic neurons are
responsible for PS genesis by means of reciprocal projections with
vlPAG/dDpMe PS-off GABAergic neurons. However, the
existence of these neurons still remained to be demonstrated.
On the other hand, we showed that the cessation of activity
during PS of the PS-off serotonergic neurons of the dorsal raphe
nucleus (DRN) and noradrenergic neurons of the locus coeruleus
(LC) is due to a tonic GABAergic input [5,6]. Combining CTb
and GAD or CTb and Fos immunostaining after PS hypersomnia,
we proposed that the PS-on GABAergic neurons at the origin of
this inhibition would be localized in the vlPAG and the dorsal
paragigantocellular reticular nucleus (DPGi) [6,7].
In summary, it is clear from previous work that PS-off and PS-
on GABAergic neurons located in the brainstem play a crucial role
in PS onset and maintenance. However, the location of these
neurons still remained to be determined. To fill this important gap,
we decided to localize all brainstem PS-on or PS-off GABAergic
neurons. For this goal, we used a highly sensitive and specific
double-staining method combining the immunohistochemical
detection of Fos with non-radioactive in situ hybridization (ISH)
of GAD67 mRNA in control rats (PSC), rats deprived of PS for
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e427272 h (PSD) with the inverted flowerpot method and rats allowed to
recover for 3 h after such deprivation (PSR). Foswas chosen because
even if it is not a perfect marker of activity [8,9,10], it is still the best
tool to map activated neurons and it was previously used to identify
the brainstem neurons responsible for PS genesis [1,3,4,11,12,13].
Since we found that the vlPAG/dDpMe region contains the large
majority of the Fos-GAD labeled neurons after PS deprivation, we
then inactivated them by Mus iontophoretic applications to
investigate the possibility that they gate the onset of PS.
Results
Neuroanatomy
Analysis of the sleep-waking cycle of the animals. During
the last 150 min before perfusion, the PSD rats displayed
negligible PS amounts (0.0360.03%; mean6sem) whereas PSC
and PSR rats spent respectively 8.8060,82% and 40.3764,17% of
their time in PS (p,0.05). The PSR animals spent significantly
more time in PS compared to the PSC rats (p,0.001). During this
period, the PSD animals spent significantly more time in W
(66.3766.38%) than the animals of the two other groups (PSC:
43.4065.64%, p,0.05, PSR: 24.1766.71%, p,0.01). In contrast
to PS and W, the quantities of SWS did not significantly differ
between the three groups of rats (PSC: 47,8064.85%, PSD:
33.6066.35%, PSR: 35.5363.57%).
Localization of the Fos-GAD double-stained neurons after
PS deprivation. The vlPAG contained a very large number of
Fos-GAD double-labeled neurons in PSD animals compared to
PSC ones (Figures 1A, B, 2A, Table 1 and Figures S1 and S2). The
double-labeled neurons constituted 55% of all the Fos-positive
(Fos
+) neurons observed in this structure. The lateral part of the
periaqueductal gray (lPAG), dDpMe (Figures 1A, B, 2A, S1, and
Figure 1. Fos
+ and GAD67 mRNA
+ neurons in the vlPAG/DpMe region and the SLD after paradoxical sleep deprivation and
hypersomnia. A,C: Low power photomicrographs showing frontal sections double-labeled for Fos and GAD67 at the level of the vlPAG/dDpMe
region in PSD (A) and PSR (C) animals. B, D: Enlargements showing several Fos
+/GAD
+ neurons (arrows) characterized by a blue diffuse cytoplasmic
staining and a brown nuclear staining in the lateral and the medial parts of the vlPAG/dDpMe region in PSD (B) and PSR (D) animals, respectively. E:
Low power photomicrograph showing a frontal section double-labeled for Fos and GAD67 at the pontine level in a PSR animal. F: Enlargement of E
showing the presence in the SLD of a large number of Fos
+ and GAD negative labeled cells characterized by a brown nuclear staining. Scale bars:
500 mm for A, C and E; 25 mm for B, D and F. Abbreviations: 3, oculomotor nucleus; Aq, Sylvius aqueduct; dDpMe, dorsal part of the deep
mesencephalic nucleus; DpMe, deep mesencephalic nucleus; DRN, dorsal raphe nucleus; DTg, dorsal tegmental nucleus; LDTg, laterodorsal tegmental
nucleus; me5, mesencephalic trigeminal tract; mlf, medial longitudinal fasciculus; PnC, pontine reticular nucleus, caudal part; SLD, sublaterodorsal
nucleus; vlPAG, ventrolateral periaqueductal gray.
doi:10.1371/journal.pone.0004272.g001
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(Gi) contained a substantial number of double-labeled cells
(Table 1 and Figures S3 and S4). Importantly, the dDpMe and
the PCRt were the only brainstem structures in which the number
of Fos-GAD neurons was significantly higher in PSD condition not
only compared to PSC but also to PSR condition (Table 1). In
addition, the double-labeled neurons localized in the dDpMe and
the most adjacent part of the vlPAG were strongly GAD-positive
(GAD
+) and mainly located at the level of the caudal oculomotor
nucleus and of the trochlear nucleus (Figure 1A, B). The
laterodorsal tegmental nucleus (LDTg) and the caudal part of
the DPGi (cDPGi) (Figures S2, S3, S4) contained a small number
of double-labeled cells in PSD condition but still significantly
above that counted in PSC condition (Table 1). Finally, the
percentage of Fos
+ neurons expressing GAD67 in the cuneiform
(CnF), lateral parabrachial nuclei (LPB) and PCRt was similar
(34.2% vs 34,9% respectively, see above), with a more substantial
number of double-labeled neurons in the PCRt compared to the
two other nuclei (Table 1 and Figures S2 and S3).
Localization of the Fos/GAD double-stained neurons
after PS recovery. At the mesencephalic level, a large
number of Fos-GAD double-labeled neurons was observed in
the interpeduncular nucleus (IP) specifically in the PSR group.
They composed 92% of the Fos
+ neurons observed in this nucleus
(Table 1 and Figure S1). At this level, a substantial number of Fos
+
cells, with 80% of them being GAD
+ were also located in the
ventral tegmental area (VTA; Table 1).
All mesencephalic and rostral pontine subdivisions of the
periaqueductal gray (PAG) contained a very large number of
Fos
+ neurons in the PSR animals significantly above the number
counted in PSC animals. However, the number of Fos
+ cells was
significantly increased compared to the PSD animals only in the
dorsolateral (dlPAG) and dorsomedial (dmPAG) subdivisions of
the PAG (Table 1). The percentage of double-labeled cells was of
52% in the vlPAG, 30% in the dlPAG and 22% in the dmPAG.
Only a small percentage of the Fos
+ neurons localized in the lPAG
were GAD
+ (11%) (Table 1). Importantly, double-labeled neurons
in the vlPAG were more abundant in the medial part of the vlPAG
just lateral to the DRN or rostral to it in PSR animals and in the
lateral and ventral portions of the vlPAG in PSD animals
(Figures 1A–D,2A, B, S1 and S2). We also found that 45% of
the Fos
+ cells in the pontine part of the PAG (CGPn) were double-
labeled (Table 1). The DRN contained a small number of Fos/
GAD double-labeled cells specifically in the PSR condition
(Table 1 and Figure S2). Finally, the DpMe contained significantly
more double-labeled cells in the PSR than in the PSC condition
(Table 1, Figure 1A, B).
In the pontine tegmentum, the LDTg contained a large number
of Fos
+ cells in PSR condition, a majority of them (52%) being
GAD
+ (Figures 1E, S2, S3 and Table 1). A small number of Fos
+
neurons mainly GAD
+ (82%) was observed in the pedunculopon-
tine tegmental nucleus (PPTg; Table 1, Figures S2 and S3). At the
same level, the dorsal tegmental nucleus of Gudden (DTg)
contained a substantial number of Fos
+ neurons for their vast
majority GAD
+ (81%; Table 1, Figure S2). Also at pontine level,
the SLD contained a substantial number of Fos
+ cells specifically
in the PSR group (Table 1, Figures 1E, F and S3). Importantly, the
small number of Fos/GAD double-labeled cells in this nucleus did
not significantly vary between the three groups of animals. The
PnC but not the PnO contained a large number of Fos-GAD
neurons in the PSR condition composing 54% of all the Fos
+
neurons (Table 1, Figures S2 and S3). In all these pontine
structures, the number of Fos-GAD labeled cells was significantly
superior compared to PSC and PSD conditions (Table 1). At the
same level, the LPB contained a large number of Fos
+ cells like in
PSD animals with only 11% of them being GAD
+ (Table 1).
At the medullary level, a large number of Fos
+ cells, mostly
GAD
+ were localized in the LPGi, DPGi, Gi, the alpha
gigantocellular reticular nucleus (GiA), the GiV and to a minor
extent the nucleus raphe magnus (RMg) in the PSR condition
(Table 1, Figures S3 and S4). Interestingly, in the DPGi, the
percentage of double-labeled cells was much higher in its caudal
part (cDPGi, 86%) than in its rostral part (rDPGi, 39%) (Table 1,
Figures 3A–D and S4). Finally, the obscurus (ROb) and pallidus
(RPa) raphe nuclei contained a small number of Fos-GAD cells
(respectively 53% and 68% of all the Fos
+) (Table 1, Figure S4).
Pharmacology
Following 20 min injections of Mus in the rostral part of the
lPAG, the LDTg, the rostral DpMe, and the caudal part of the
vlPAG, no change was observed compared to saline injections
regarding the sleep-wake cycle (i.e. W, SWS and PS quantities,
number of PS episodes and absence of SOREM) (n=15;
Figure 4A). When Mus injections (n=9) were centered either on
the intermediate and caudal part of the lPAG, the ventral part of
the DpMe and the rostral part of the vlPAG, a total disappearance
of sleep (SWS and PS) concomitant with a strong excitation of rats
was observed compared to saline injections (Figure 4A).
In contrast, following injections of Mus into the vlPAG/dDpMe
region (n=5) (Figures 4 and S5),a dramatic increasein PS quantities
Figure 2. Activated GABAergic neurons in the vlPAG/DpMe region after paradoxical sleep deprivation and hypersomnia (Fos
immunohistochemistry combined with GAD67 mRNA in situ hybridization). Schematic distribution of Fos
+ (small black dots) and Fos-GAD
(large red dots) neurons in the vlPAG/dDpMe region in PSD (A) and PSR (B) animals (sections 27.40 from Bregma). Double-labeled neurons in the
vlPAG are more abundant in the lateral and ventral portions of the vlPAG in the PSD animal and in its medial part in the PSR animal.
doi:10.1371/journal.pone.0004272.g002
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n Fos+Total Fos+/GAD+ %GAD/Fos
PSC PSD PSR PSC PSD PSR PSC PSD PSR
Mesencephalum
IP 3 2.360.5 10.561.7 99.5622.8***
,### 1.060.4 6.860.9 90.0617.1***
,### 54.2620.8 66.566.1 92.463.4
SNC 2 2.062.0 8.863.1 16.069.5 1.061.0 8.362.7 14.369.7 12.5612.5 97.162.9 72.4610.7
SNR 2 2.061.4 13.565.9 30.5623.7 1.060.7 12.565.6 28.8623.2 25.0614.4 90.465.5 86.267.7
VTA 4 4.862.2 21.865.8 59.3621.4* 3.862.5 14.365.2 47.5618.5* 54.2620.8 57.0611.5 80.064.0
Periaqueductal gray
dlPAG 5 20.367.3 50.066.0 244.0667.9** 3.361.6 12.062.7 73.3619.9**
,## 16.564.9 23.262.2 29.863.8
dmPAG 5 10.562.4 29.066.7 140.5623.5***
,### 1.860.9 7.562.7 29.562.4***
,### 14.065.0 24.064.7 22.262.9
lPAG 5 38.0619.7 211.5624.2*** 298.0619.7***
,# 3.561.2 43.8610.6** 33.564.1** 12.364.4 19.763.8 11.461.4
vlPAG 5 37.8613.8 238.5623.6*** 358.0667.5** 24.368.2 129.8612.0** 183.3631.2*** 63.265.4 54.661.9 52.064.1
CGPn 3 15.364.7 33.568.5 60.0614.8* 5.563.9 14.063.5 27.867.4* 27.7611.8 49.0617.3 45.467.2
DRN 2 4.061.7 20.069.4 16.563.8 2.061.2 5.561.5 9.562.0** 32.5619.7 36.8614.0 59.566.5
Pontomesencephalic tegmenti
PPTg 1 1.060.7 3.060.4 13.864.2**
,# 1.060.7 2.860.5 11.063.0**
,## 50.0628.9 91.768.3 82.266.4
LDTg 2 7.863.6 30.563.1* 78.8610.5***
,### 5.362.2 23.363.5** 40.864.7***
,## 82.3610.4 75.566.3 52.564.1
DTg 2 2.360.8 12.861.4* 28.565.2***
,## 2.360.8 7.061.7 23.364.5***
,## 100.060.0 54.7612.3 80.862.0
Mesopontine reticular formation
dDpMe 4 8.062.9 44.062.4*** 44.563.0*** 4.061.6 30.862.4*** 19.364.8**
,# 50.8610.3 70.366.1 42.268.7
DpMe 5 17.067.0 149.5651.5 258.0676.2** 10.065.0 75.8621.7 112.3638.2* 42.8614.9 53.462.7 38.269.1
SLD 2 7.363.1 14.563.1 55.5613.0**
,## 4.862.4 7.861.1 8.361.9 67.0615.3 57.369.0 15.363.0
PnO 1 2.561.5 24.5611.1 71.0623.5**
,## 1.861.4 12.065.4 26.069.0 31.3623.7 50.567.6 38.864.1
PnC 2 10.366.5 70.5618.5 130.5638.5** 6.065.3 35.367.0 68.0620.9** 34.2617.5 52.967.2 53.867.4
PnV 1 0.860.5 6.363.0 14.562.8**
,# 0.360.3 5.062.5 9.062.9 25.0625.0 58.0619.6 60.3610.7
Dorsolateral pons
CnF 1 10.063.2 23.363.8* 32.864.7** 3.061.2 7.562.9 6.061.2 41.5616.9 34.2612.7 19.064.0
LPB 2 11.061.3 89.0618.7* 111.8637.1* 3.061.0 5.562.3 10.862.5 26.165.8 5.561.6 11.062.3
LC 1 0.860.5 1.560.6 1.361.3 0.060.0 0.060.0 1.061.0 0.060.0 0.060.0 20.0620.0
KF 1 2.560.9 18.365.6 17.565.8 0.560.5 0.060.0 2.560.6*
,## 16.7616.7 0.060.0 23.369.3
MnR 3 1.060.7 12.563.9 18.566.3* 0.860.5 1.560.6 7.561.8**
,## 41.7625.0 11.965.8 45.068.1
Medullary reticular formation
PCRt 6 25.0612,0 116.8634.1 70.5623.9 8.364.1 40.3610.7* 14.864.8
# 30.464.9 34.962.3 25.367.1
Gi 5 6.062.0 68.0614.6* 106.8627.2** 3.361.4 32.367.1* 58.3612.5** 40.6614.4 46.863.4 56.767.3
GiA 3 9.363.7 37.068.4 96.8614.2***
,## 3.861.0 23.063.7 63.069.7***
,## 59.7616.3 66.367.5 64.761.9
GiV 2 3.361.5 15.062.7 59.5610.9***
,### 2.361.3 4.560.5 51.869.2***
,### 46.4617.6 34.168.1 87.863.1
rDPGi 1 0.860.5 3.861.4 25.566.2***
,## 0.560.3 3.561.5 10.364.1 37.5623.9 66.7623.6 38.7610.3
cDPGi 3 5.061.2 19.065.0 57.3615.7***
,# 4.061.1 13.562.8* 47.5611.9**
,## 80.268.2 75.0610.2 86.064.3
LPGi 5 24.067.4 79.3612.9 203.5647.8**
,# 19.865.7 42.864.5 145.8638.8**
,## 84.664.3 55.663.7 70.764.8
RMg 4 5.062.7 29.866.6* 47.5611.4** 4.062.0 16.061.7 39.368.8**
,# 85.968.4 59.969.2 83.563.0
ROb 2 1.060.7 7.561.9* 8.362.6* 0.560.5 0.360.3 4.361.3**
,## 16.7616.7 2.562.5 53.368.2
RPa 6 8.864.9 29.062.7** 28.863.8** 2.861.8 8.062.5 19.062.1***
,## 70.0623.8 26.568.2 68.368.3
Number (mean6sem) of Fos
+ and Fos-GAD neurons counted in the brainstem in PSC, PSD and PSR rats on a total of 13 sections at 600 mm intervals through the full
rostro-caudal extent of the pons and medulla after Fos immunohistochemistry combined with GAD67 mRNA in situ hybridization. The values displayed are an average
across 4 animals in each group of the sum of all Fos
+ neurons (Fos
+Total) and Fos/GAD67 double-labeled neurons (Fos
+/GAD
+) counted on one or several sections
(column n) depending on the rostrocaudal extent of the structures. %GAD/Fos indicates the percentage of Fos
+ neurons that are GABAergic. Significance values
indicated for individual points are: *P,0.05, **P,0.01 and ***P,0.001 vs PSC;
#P,0.05,
##P,0.01 and
###P,0.001 between PSR and PSD. Abbreviations: cDPGi,
caudal part of the dorsal paragigantocellular nucleus; CGPn, central gray of the pons; CnF, cuneiform nucleus; dlPAG, dorsolateral periaqueductal gray; dmPAG,
dorsomedial periaqueductal gray; dDpMe, dorsal part of the deep mesencephalic nucleus; DpMe, deep mesencephalic nucleus; DRN, dorsal raphe nucleus; DTg, dorsal
tegmental nucleus; Gi, gigantocellular reticular nucleus; GiA, gigantocellular reticular nucleus, alpha part; GiV, gigantocellular reticular nucleus, ventral part; IP,
interpeduncular nucleus; KF, Ko ¨lliker–Fuse nucleus; LC, locus coeruleus; LDTg, laterodorsal tegmental nucleus; lPAG, lateral periaqueductal gray; LPB, lateral parabrachial
nucleus; LPGi, lateral paragigantocellular nucleus; MnR, median raphe nucleus; PCRt, parvicellular reticular nucleus; PnC, pontine reticular nucleus, caudal part; PnO,
pontine reticular nucleus, oral part; PnV, pontine reticular nucleus, ventral part; PPTg, pedunculopontine tegmental nucleus; rDPGi, rostral part of the dorsal
paragigantocellular nucleus; RMg, raphe magnus nucleus; ROb, raphe obscurus nucleus; RPa, raphe pallidus nucleus; SLD, sublaterodorsal nucleus; SNC, substantia
nigra, compact part; SNR, substantia nigra, reticular part; vlPAG, ventrolateral periaqueductal gray; VTA, ventral tegmental area.
doi:10.1371/journal.pone.0004272.t001
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(9.362.9% of total time). PS quantities were increased by 342%
compared to NaCl (p=0.0003) concomitant to a non significant
decrease of SWS and W. The dramatic increase of PS was due to an
increase in the number of PS episodes (1.360.3 for NaCl versus
3.560.2 episodes for Mus, an increase of 260%, p=0.0007) and not
of their duration (1.860.15 min versus 1.360.4 min). The increase
of PS started with a mean latency of 7.161 . 3m i na n de n d e d1h o u r
after the beginning of the Mus injection (Figure 4B). Importantly,
17.3% of the episodes of PS occurring after Mus injections appeared
directly after W without a transition by SWS like after saline
injections. The episodes of PS occurring after Mus and saline
injections were similarly characterized by a cortical EEG desynchro-
nization combined with a muscle atonia and rapid eyes and vibrissae
movements (Figure 5A, B and video S1). They also showed the same
spectral composition of the EEG (Figure 5C).
Discussion
In the present study, we demonstrate by means of combined Fos
and GAD staining and Mus local applications that large
populations of PS-off and PS-on GABAergic neurons are localized
in the vlPAG and the adjacent dDpMe and that inactivation of
these neurons by Mus induces a large increase in PS quantities.
These results suggest that the vlPAG is the most important
structure for PS control by mean of its PS-off and PS-on
GABAergic neurons. We further showed that SLD PS-on neurons
triggering the state of PS [1,14] are not GABAergic indicating that
PS is not generated by a flip-flop switch between PS-on
GABAergic neurons localized in the SLD and GABAergic PS-
off neurons localized in the vlPAG as recently proposed [4].
Finally, we unexpectedly found that several medullary reticular
nuclei contain substantial populations of PS-on GABAergic
neurons indicating that GABA in addition to glycine play an
important role in sensory and motor inhibition during PS.
Inthepresentstudythechangesinc-Fosexpressionareinterpreted
as reflecting changes in neuronal activity associated with the different
experimental conditions. It must be mentioned, nonetheless, that
such changes may also reflect changes in other cellular processes that
can be stimulated by chemical messengers independent of neuronal
discharge, although also dependent on changes in intracellular
calcium [15]. In spite of these limitations, c-Fos immunostaining is
considered to be a useful tool to map activated neurons [16].
Here we show that the distribution and number of Fos
+ labeled
neurons were similar with our previous publications using the
same deprivation recovery method [7,17] validating our protocol
Figure 3. Activated GABAergic neurons at medullary level after paradoxical sleep hypersomnia. Photomicrographs of Fos (brown
nuclear staining) and GAD67 mRNA (blue diffuse cytoplasmic staining) double-labeled sections from PSR rats at the medullary level. Low (A) and high
(B) power photomicrographs showing the rDPGi. Numerous Fos
+ and GAD-negative neurons are observed in this structure at high magnification (B).
(C–F) Photomicrographs showing low (C) and high magnifications (D–F) of the medullary reticular nuclei in a PSR animal. Note the presence of
numerous Fos-GAD cells (black arrows) in the DPGi (D), the GiV (E) and the LPGi (F). Abbreviations: 4 V, 4
th ventricle; Amb, ambiguus nucleus; Cb,
cerebellum; g7, genu of the facial nerve; mlf, medial longitudinal fasciculus; cDPGi, caudal part of the dorsal paragigantocellular nucleus; GiV,
gigantocellular reticular nucleus, ventral part; IO, inferior olive; LPGi, lateral paragigantocellular nucleus; MVe, medial vestibular nucleus; Pr, prepositus
nucleus; rDPGi, rostral part of the dorsal paragigantocellular nucleus. Scale bars, 500 mm for A and C; 50 mm for B, E and F and 25 mm for D.
doi:10.1371/journal.pone.0004272.g003
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however largely different with those obtained in the three previous
studies reporting the distribution of GAD- and Fos-immunoreac-
tive neurons using nearly the same protocol than us excepting a
shorter 48 h PS deprivation [3,11,12]. We indeed also observed
significantlymoreFos-GAD double-labeled cells inthe VTA,LDTg,
Figure 4. Muscimol injection sites inducing paradoxical sleep hypersomnia. A: Localization on rostro-caudal frontal sections (ß, Bregma) of
the Mus injections sites inducing either a PS hypersomnia (black circles), a strong excitation of the animals (grey circles) or no effects on the sleep-
wake cycle (empty circles). One circle can represent one or more ejections. B: Percentages of the three vigilance states before and after Mus and NaCl
iontophoretic ejections (n=5) in the vlPAG/dDpMe region. Significance values indicated are: *P,0.05, **P,0.01 and ***P,0.001 vs NaCl.
doi:10.1371/journal.pone.0004272.g004
Figure 5. Paradoxical sleep characteristics after muscimol injection in the vlPAG/dDpMe region. A: EEG spectrogram analysis of the
3000 s following one Mus ejection in the vlPAG/dDpMe region. Rectified EMG amplitude, EEG trace and spectrogram analysis are presented for 200 s
corresponding to one PS episode induced by the Mus ejection. B: PS episodes induced by Mus ejections share the same properties as the control one,
an active EOG, a flat EMG and a dominant theta band frequency activity. C: Average power spectrum analysis for Mus and NaCl ejections in the vlPAG/
dDpMe region.
doi:10.1371/journal.pone.0004272.g005
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compared to control and PSD condition and in the total number of
Fos
+ neurons in the PnO. However, for the latter structure as well as
the substantia nigra, median raphe and SLD, we did not observe a
change in the number of Fos-GAD neurons in PSR animals
compared to the PSD and PSC ones. Further, in contrast to the
previous studies, we observed numerous Fos
+ neurons in the SLD,
CGPn, PnC, Gi, GiA, GiV, RMg and the ROb and numerous Fos/
GAD labeled neurons in the PnC, cDPGi, GiV and the ROb
specificallyinPSrecoveryrats.Finally,we described for thefirst time
the presence of a large number of Fos-GAD double-labeled cells in
the vlPAG, dDpMe and PCRt both after PS deprivation and
recovery and in the dlPAG, dmPAG, CGPn, IP and DTg only after
PS recovery. These discrepancies are likely due to the fact that the
Fos antibody used in Maloney et al. [3,11,12] studies labeled a large
number of cells in basal condition in contrast to the one used in our
and the other previous Fos studies likely precluding them to extract
the Fos staining specifically induced by the protocol. Further, the
development and use in our study of the highly sensitive ISH instead
of immunohistochemistry to label GAD-containing neurons likely
contributed to a more complete identification of GABAergic
neurons.
Functional role of the GABAergic neurons activated
during PS deprivation
We showed for the first time that PS deprivation activates a
large number of GABAergic neurons only in the vlPAG/dDpMe
region. The PCRt was the only other brainstem structure
containing a substantial number of double-labeled neurons after
PS deprivation. Furthermore, we demonstrated that unilateral
Mus iontophoretic injections specifically in the vlPAG/dDpMe
region induced a strong increase in PS quantities. These
pharmacological data are coherent with what has been shown in
guinea pigs [18], cats [19,20] and after chemical lesions in rats [4].
These results combined with our previous pharmacological and
neuroanatomical results [1,2,21] indicate that PS-off GABAergic
neurons localized in the vlPAG/dDpMe region inhibit PS onset
during W and SWS by means of a tonic inhibitory input to the
SLD PS-on neurons. In addition, we found that 17% of the PS
episodes induced by Mus injections appeared directly after W like
the SOREMs of narcolepsy [22]. These results combined with the
previous findings of hypocretin fibers and receptors in the vlPAG/
dDpMe region [4,23,24] support the hypothesis that the SOREM
and the cataplexy seen in narcoleptics could be due to the lack of
an excitatory hypocretin input to the PS-off GABAergic neurons
of the vlPAG/dDpMe region (Figure 6).
Figure 6. Model of the network responsible for PS onset and maintenance. The SLD contains glutamatergic neurons responsible for the
onset and maintenance of PS. They induce muscle atonia and sensory inhibition via direct excitatory projections to the glycinergic/GABAergic
neurons localized in the medullary ventral reticular nuclei (GiA, GiV, RMg) and EEG activation via direct intralaminar thalamic projections. DuringW
and SWS, the SLD neurons are tonically inhibited by GABAergic PS-off neurons localized in the vlPAG/dDpMe region. At the onset and during PS
these PS-off neurons are tonically inhibited by the co-localized GABAergic PS-on neurons as well as those of the DPGi and LPGi. These GABAergic PS-
on neurons are also responsible for the inhibition of locus coeruleus (LC) noradrenergic and dorsal raphe (DRN) serotonergic neurons during PS. In
normal condition, the onset of PS is not possible directly from W because the wake-active hypothalamic hypocretinergic neurons and brainstem
monoaminergic neurons tonically excite the vlPAG/dDpMe PS-off GABAergic neurons. The decrease or cessation of activity of these wake-active
neurons during SWS weaken the activity of vlPAG/dDpMe PS-off GABAergic neurons inducing a desinhibition of the co-localized GABAergic PS-on
neurons and by this way PS.
doi:10.1371/journal.pone.0004272.g006
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After PS recovery, a large number of Fos
+/GAD
+ neurons was
observed in the vlPAG and to a minor extent the dlPAG, dmPAG
and the lPAG. A large number of Fos-GAD labeled cells was also
seen in the vlPAG after PS deprivation (see above) indicating that
this structure contains GABAergic neurons activated during PS
deprivation and PS rebound. It is likely that these GABAergic
neurons form two distinct populations of PS-off and PS-on
neurons, respectively. Indeed, the majority of the double-labeled
neurons after PS deprivation were localized in the lateral and
ventral portion of the vlPAG whereas they were more numerous in
the medial part of the vlPAG just lateral to the DRN or rostral to it
after PS recovery. Further, we previously showed that a substantial
number of Fos
+ vlPAG neurons labeled after PS recovery but not
after PS deprivation project to the LC [7].
In our previous studies [5,6], we demonstrated that GAD-IR
neurons of the vlPAG project to the DRN and that the cessation of
activity of DRN serotonergic and LC noradrenergic neurons
during PS is reversed by the iontophoretic application of Bic, a
GABAA antagonist [5,6]. Based on these previous and the present
results, we propose that the PS-on GABAergic neurons localized in
the vlPAG inhibit during PS the DRN serotonergic and LC
noradrenergic neurons and the co-distributed vlPAG/dDpMe
GABAergic PS-off neurons inducing by this way the desinhibition
of the SLD PS-on neurons. Reciprocally, during W and SWS the
vlPAG/dDpMe GABAergic PS-off neurons would inhibit PS by
their projections to the co-distributed GABAergic PS-on neurons
and the SLD glutamatergic PS-on neurons (Figure 6). However,
since Mus injection in the vlPAG/dDpMe region inhibits at the
same time the PS-off and PS-on GABAergic neurons localized in
this area and nevertheless induces an increase of PS quantities, it
might be concluded that the activation of the vlPAG PS-on
GABAergic neurons is not essential to obtain PS. It might also
indicate that the main function of these neurons is to inhibit the
co-localized GABAergic PS-off neurons during PS whereas their
role in inhibiting the monoaminergic neurons is not essential.
Indeed PS-on GABAergic neurons of the DPGi also likeky
contribute to this inhibition (see below and [21]). Our results only
partly fit with the recent model of Lu et al. [4] who proposed that
the genesis of PS is due to a GABAergic inhibitory reciprocal
interaction between PS-on GABAergic neurons localized in the
SLD and GABAergic PS-off neurons from the vlPAG/dDpMe
region. Indeed, our findings that the small number of Fos-GAD
neurons in the SLD did not change in PSC, PSD and PSR animals
whereas the total number of Fos
+ neurons significantly increased
in the PSR condition are not fitting with this model. It is more
likely that the Fos
+ neurons observed in the SLD specifically after
PS recovery are glutamatergic. Indeed, Lu et al. [4] also reported
the presence of vGlut2 containing neurons in the SLD and we
have shown that when SLD neurons are desinhibited by Bic, they
excite glycinergic neurons of the RMg, GiA and Giv and also the
intralaminar thalamic relay neurons [1].
Specifically after PS recovery, five medullary nuclei, the GiA,
GiV, RMg, DPGi and LPGi contained a large number of Fos
+
neurons, mostly GAD-positive. It has been previously shown that
the GiA, GiV and RMg display a large contingent of glycinergic
neurons [25] projecting directly to spinal motoneurons [26]. We
also showed that glycinergic neurons from these nuclei express Fos
after a pharmacological induction of PS [1,13]. In addition, it has
been shown that strychnine (a glycine antagonist) but not Bic
iontophoresis on motoneurons reverse their hyperpolarization
during PS indicating that the premotoneurons responsible use
glycine and not GABA to hyperpolarize them during PS [27].
Nevertheless, it was more recently shown that both the release of
glycine and GABA increase in the spinal cord and the hypoglossal
motor nucleus during the atonia produced by a cholinergic
stimulation of the peri-LCa (cat equivalent of the SLD)[28].
Altogether, the present and previous results suggest that the GiV,
GiA and RMg PS-on neurons responsible for sensory and motor
inhibition during PS co-contain glycine and GABA.
Besides, we previously showed that Fos
+ cells localized in the
DPGi after PS recovery were retrogradely-labeled after CTb
injection in the LC [7]. We further showed that the DPGi project
to the vlPAG/dDpMe region and to a minor extent to the DRN
and the hypothalamic region containing the hypocretin neurons
[29]. GABAergic PS-on neurons of the DPGi identified in the
present study could therefore in cooperation with those of the
vlPAG/dDpMe region participate in the inhibition of the
monoaminergic and the vlPAG/dDpMe PS-off GABAergic
neurons at the onset and during PS (Figure 6). Finally, we
surprisingly found that the LPGi was the second structure after the
PAG containing the largest number of Fos-GAD neurons after PS
recovery. Since a small subset of Fos
+ cells localized in the LPGi
after PS recovery project to the LC [7], we propose that LPGi PS-
on GABAergic neuron contribute to the inhibition of the PS-off
neurons during PS.
Conclusions: a revised model for PS control
The results described in the present study provide substantial
progress in the identification of the network responsible for PS
control. From these results and previous ones, we propose a
revised model for PS control (Figure 6). This model provides a new
framework for the identification of the mechanisms controlling PS
onset and maintenance and a better understanding of sleep
disorders such as narcolepsy and REM sleep behavior disorder.
Materials and Methods
All experiments were conducted in accordance to the French
and European Community guidelines for the use of animals in
research. Sprague–Dawley rats were housed individually and
placed under a constant light/dark cycle (light on from 7:00 AM to
7:00 PM). The room temperature was maintained at 2161uC and
standard rodent food and water were available ad libitum
throughout the experiment. The protocols were approved by the
institutional animal care and use committee of the University of
Lyon 1 (protocols BH 2006-10, BH 2006-09 and BH 2006-07).
Neuroanatomy
Animal and surgery. Briefly [7,17,30], twelve male Sprague-
Dawley rats (200–230 g, Charles River, France) were implanted
with electroencephalogram (EEG) and electromyogram (EMG)
electrodes under chloral hydrate anesthesia (400 mg/kg, i.p.). Four
stainless steel screws were fixed in the occipital, parietal and frontal
parts of the skull and two wire electrodes inserted into the neck
muscles to monitor the EEG and the EMG, respectively. All leads
were connected to a miniature plug that was cemented to the skull.
After surgery, rats were placed in a Plexiglas jar covered with
woodchips for the duration of the experiment. Animals were
allowed 5 days of recovery from surgery in the animal room before
being placed in a recording chamber for 4 days, time necessary for
a good habituation to the recording conditions (recording chamber
and cable).
Polygraphic recordings. Rats were connected to a cable
attached to a rotative connector to allow free movement of the
animal within the jar. EEG and EMG recordings were collected
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(Cambridge Electronic Design, Cambridge, UK).
Paradoxical sleep deprivation procedure. PS deprivation
was performed using the flower pot technique that has been
previously shown to induce a fairly selective deprivation of PS in
rats [3,7,11,17,30,31]. This procedure does not cause significant
changes in adrenal gland weights [31] and plasma corticosterone
levels [32], two physiological parameters used to estimate the stress
level in animals. Moreover, EEG spectral characteristics of W,
SWS and PS states are not modified during the PS deprivation and
the recovery period compared to baseline recordings [11].
Rats were divided in 3 groups: control (PSC), deprived of PS for
,72 h (PSD) and rats allowed to recover for ,3 h after such
deprivation (PSR) (n=4 for each group). The PSC animals
remained on a bed of woodchips in the recording room
throughout the experiment. On the first day (9:00 AM) and after
48 h of baseline, PSD and PSR rats were placed on a platform
surrounded by 2 cm of warm water for 72 h. The platform was
just large enough (6.5 cm in diameter) to hold the animal. In this
situation, the animal could engage in SWS but not PS, because of
the loss of muscle tonus occurring at PS onset. Everyday in the
morning (between 9:00 and 10:00 A.M.), in order to clean their
jar, rats were removed from their platform and placed in a
Plexiglas jar. The last day, PSC animals were first anesthetized for
perfusion (at ,1:00 P.M.). PSD animals were secondly anesthe-
tized for perfusion (at ,1:00 P.M.), after 75 h of PS deprivation.
The PSR animals were also removed from their cages (10:00
A.M.) and were returned to a dry bed of woodchips in their
recording jars to allow PS recovery. PSR rats were anesthetized for
perfusion (at ,1:00) exactly 150 min after the first PS episode
occurring generally after ,30 min of exploration and grooming.
Perfusion and fixation. Under profound barbiturate
anesthesia (pentobarbital, Ceva sante ´ animale, 150 mg/kg, i.p.),
rats were transcardially perfused with Ringer’s lactate solution
containing 0.1% heparin, followed by 500 ml of a fixative solution
composed of 4% paraformaldehyde in 0.1 M phosphate buffer
(PB, pH 7.4). The brains were then stored at 4uC for 1 night in the
fixative solution and for at least 3 days in 30% sucrose in 0.1 M
PB. After that, they were rapidly frozen with CO2 gas and 30 mm-
thick coronal sections were cut on a cryostat. The free-floating
sections were collected and stored at 220uC in a RNase free
cryoprotectant solution (0.05% DEPC, 20% glycerol, 30% ethylen
glycol in 50 mM PB, pH 7.4).
Fos immunohistochemistry combined with GAD67 mRNA
in situ hybridization. As described before [33], the
recombinant plasmid containing the GAD67 cDNA was
linearised using EcoRV and transcribed using SP6 RNA
polymerase and a nonradioactive RNA labeling kit (Roche
Diagnostic, Mannheim, Germany) for the antisense probe. The
brain sections were successively incubated in a rabbit antiserum to
Fos (1:4000; Ab-5; Oncogene, CA, USA) in 10 mM PB containing
0.9% NaCl and 0.3% Triton-1006 (PBST) for 18 h at room
temperature; a biotinylated goat antirabbit IgG solution (1:1000;
Vector Laboratories, Burlingame, CA, USA); and an ABC-HRP
solution (1:1000; Elite kit, Vector Laboratories) both for 90 min at
room temperature. Finally, the sections were immersed in a
0.05 M Tris-HCl buffer (pH 7.6) containing 0.025% 3.39-
diaminobenzidine-4 HCl (DAB, Sigma-Aldrich, St. Louis, MO,
USA) and 0.003% H2O2. Three washes of 10 min in PBST were
performed between each step. The sections were then rinsed two
times in PBST containing 10 mM dithio-threitol (DTT, Sigma-
Aldrich) for 10 min at room temperature and then in standard
saline citrate solution (SSC 26) for 10 min also at room
temperature. All the buffers excepting DTT contained 0.2% of
RNase inhibitor (solution Protect RNA RNase inhibitor, Sigma-
Aldrich). After these rinses, the sections were placed for 18 h at
65uC in a hybridization buffer consisting of NaCl (150 mM), Tris-
HCl (8 mM), Tris-Base (1 mM), NaH2PO4 (6 mM), Na2HPO
(5 mM), EDTA (5 mM), formamide (50%), dextran sulphate
(10%), yeast tRNA (Sigma type III, 1 mg/ml, Sigma-Aldrich),
ficoll (0.02%), polyvinylpyrrolidone (0.02%) containing 0.5 mg/ml
of the digoxigenin-labeled probe. After hybridization, the sections
were washed in SSC 16, 50% formamide, 0.1% Tween-20 at
55uC twice for 20 min and treated with 10 mg/ml RNase A (USB,
Cleveland, OH, USA) in Tris 10 mM (pH 8.0) containing 1 mM
EDTA and 500 mM NaCl for 15 min at 37uC. They were then
rinsed 3610 min at room temperature with PBST. For
immunohistological detection of digoxigenin (DIG), the sections
were incubated overnight at room temperature with anti-DIG
conjugated to alkaline phosphatase (Roche Diagnostic) diluted
1:2000 in PBST containing 0.2% blocking agent (Roche
Diagnostic). After incubation, the sections were washed in PBST
twice for 10 min and then in a buffer containing 100 mM Tris
(pH 9.5), 100 mM NaCl and 50 mM MgCl2. The sections were
developed at 37uC for ,4 h in the same buffer with nitroblue
tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl-phosphate
(BCIP) diluted 1/50 from the stock solution (Roche Diagnostic).
Finally, the sections were mounted on glass slides, dried and
coverslipped with Vectamount (Vector Laboratories). Controls in
the absence of primary antibodies (anti-Fos and anti-DIG) and
with the sense probe (GAD67 cDNA linearised using HindIII and
transcribed using T7 RNA polymerase) were run to ensure the
absence of nonspecific labeling. As specified by the supplier, the
Fos antiserum was made against a synthetic peptide corresponding
to the N-terminal part (residues 4–17) of human Fos. This part of
the protein displays 100% homology between human and rat (van
Straaten et al., 1983; Curran et al., 1987) and no homology with
Fos-related antigens such as Fos B, Jun B, Fra-1 and Fra-2 (Blast 2
sequences, NCBI). In agreement with previous studies, very few
immunoreactive (IR) nuclei were observed in the rat brain with
this Fos antiserum following perfusion during daylight (Semba et
al., 2001; Ro et al., 2003; Gong et al., 2004). Brains from sets of
PSC, PSD, PSR animals that were run together experimentally
were processed together for immunohistochemistry and ISH.
Analysis of sleep-wake state data. Vigilance states were
discriminated with the aid of EEG and EMG data as previously
described (Maloney et al., 2002). For 3 rats per condition, the last
3 h of EEG/EMG recordings before perfusion were analyzed in
order to determine quantities, number and duration of periods of
W, SWS and PS.
Analysis of double labeling. Because the distributions of
Fos+ and Fos-GAD neurons were similar on both brain sides, only
hemi-sections were analyzed. Drawings of double-labeled sections
were made with anAxioscope microscope (Zeiss, Germany) equipped
with a motorized X–Y-sensitive stage and a video camera connected
toacomputerizedimageanalysissystem(Mercator;ExploraNova,La
Rochelle, France). Single- and double-labeled neurons were plotted
on sections taken at 600 mm intervals (13 sections between AP 25.60
and 212.80 from Bregma). The number of Fos
+ and Fos-GAD
plotted neurons per structure was automatically counted and
exported using Mercator (ExploraNova). When a structure was
present on several sections the neurons counted on all sections were
summed. The counts were not performed in the superior and inferior
colliculus.TheatlasofPaxinos&Watson[34]wasusedasareference
for all structures except the SLD which was named and delineated
according to Swanson [35].
Statistical analysis. Analyses of variance (ANOVA) tests
were performed on the different vigilance states and the number of
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(PSC, PSD and PSR). Post-hoc PLSD Fisher tests were used to
identify significant pairwise differences (PSR or PSD vs PSC; PSR
vs PSD). All statistics were performed using Statistica 6.0.
Pharmacology
The head-restrained rat method. The method has been
previously described in detail [1,5,6]. Briefly, male Sprague–
Dawley rats (280–320 g, n=7; Charles River, France) were
anaesthetized with chloral hydrate (400 mg/kg, i.p) and mounted
conventionally in a stereotaxic frame (David Kopf, CA, USA). The
skull was placed at a 15u angle (nose tilted down) and an additional
angle of 15u was applied to the micromanipulator (leading to a
total angle of 30u) to avoid the transverse sinus overlying the
vlPAG/dDpMe region during the subsequent electrode
penetrations. Five electrodes were fixed in the skull bilaterally
above the frontal (Bregma +4 mm AP and 62 mm L) and parietal
(Bregma 23 mm AP and 63 mm L) cortices, and unilaterally
above occipital cortex (Bregma 29 mm AP and 23m mL )t o
monitor the EEG. Two wire electrodes were inserted into the neck
muscles and two electrodes were inserted behind each ocular globe
to monitor EMG and electrooculogram (EOG). The rats were
habituated to the restraining and recording system for 8–10 days.
At the end of the training, they could stay calm for 5–6 h daily
sessions with a normal sleep-wake cycle. Two days before the first
pharmacological session, under pentobarbital and local lidocaine
anesthesia, a 4 mm hole was drilled over the vlPAG/dDpMe
region to remove the dura under microscopic control. At the
beginning of each recording session, the brain surface was cleaned
under local lidocaine anesthesia.
Pharmacological protocol. Daily recording sessions were
typically performed over a maximum of 7–10 days, each session
lasting ,4–6 hr. Drugs (Mus 10 mM, pH 4, Sigma; NaCl 0,9%;
Phaseolus vulgaris leucoagglutinin, PHA-L, 1%, Vector Laboratories
or Fluorogold, Fg, 4%) were applied iontophoretically during the
light-on sleep period (between 10 a.m. and 1 p.m.) with a multi-
barrel micropipette (20 mm tip diameter) lowered into the vlPAG/
dDpMe region. Once the pipette was in place, and after a 15 min
baseline recording, Mus or saline was ejected iontophoretically for
20 min at 100 nA. After the end of this injection, sleep-waking
cycle was recorded for 1 h. Mus or saline (20 min, 100 nA) was
injected in the same site at least 2 h after the end of the first
recording. For each rat, one injection of tracer (PHA-L, Fg) was
applied in the first Mus-positive injection site to localize it (Figure
S5). At the end of the last injection, the rats were sacrificed under
anesthesia and perfused with a fixative solution as described above.
Data analysis. W, SWS and PS were determined throughout
the experiment on 10 s epochs by visual inspection of the EMG,
EEG and the EEG power spectrum. Hypnograms were then
drawn using a homemade script in Spike-2 software (CED). Each
recording was decomposed on 4 consecutive 20 min epochs after
the beginning of the Mus or saline injection. The effect latency was
defined as the time-interval between the onset of drug application
and the appearance of the first PS episode. The duration of the
effect was defined as the time-interval between the effect onset and
the moment at which the mean PS quantity value returned to the
baseline value. The EEG spectral power was calculated with a
Spike-2 script computing a fast Fourier transform on 10 s EEG
epochs (0.1 Hz resolution). The EEG spectrogram was obtained
using the ‘specgram.m’ function of Matlab (Math-Works, Natick,
Massachusetts, USA). For this purpose, a sliding window Fourier
transform was applied to the EEG signal using a 1 s window with a
0.25 s overlap. The mean6SEM of the vigilance states quantities
were calculated for the effect of Mus and compared with those
observed with saline injections using ANOVA followed by post hoc
Bonferroni tests.
Supporting Information
Figure S1 Schematic distribution of Fos+ (small black dots) and
Fos-GAD (large red dots) neurons on coronal sections taken at
600 mm intervals from 25.60 and 26.80 from Bregma in a
representative animal for PSC (left hand side), PSD (middle) and
PSR (right hand side) conditions after Fos immunohistochemistry
combined with GAD67 mRNA in situ hybridization. Abbrevia-
tions: 3, oculomotor nucleus; cp, cerebral peduncle, basal part;
dlPAG, dorsolateral periaqueductal gray; dmPAG, dorsomedial
periaqueductal gray; dDpMe, dorsal part of the deep mesence-
phalic nucleus; DpMe, deep mesencephalic nucleus; IP, interpe-
duncular nucleus; lPAG, lateral periaqueductal gray; ml, medial
lemniscus; mlf, medial longitudinal fasciculus; PaR, pararubral
nucleus; R, red nucleus; RRF, retrorubral field; SNC, substantia
nigra, compact part; SNR, substantia nigra, reticular part; vlPAG,
ventrolateral periaqueductal gray; VTA, ventral tegmental area.
Found at: doi:10.1371/journal.pone.0004272.s001 (9.56 MB TIF)
Figure S2 Schematic distribution of Fos+ (small black dots) and
Fos-GAD (large red dots) neurons on coronal sections taken at
600 mm intervals from 27.40 to 28.60 from Bregma in a
representative animal for PSC (left hand side), PSD (middle) and
PSR (right hand side) conditions after Fos immunohistochemistry
combined with GAD67 mRNA in situ hybridization. Abbrevia-
tions: 4, trochlear nucleus; CGPn, central gray of the pons; CnF,
cuneiform nucleus; cp, cerebral peduncle, basal part; DLL, dorsal
nucleus of the lateral lemniscus; dlPAG, dorsolateral periaque-
ductal gray; dmPAG, dorsomedial periaqueductal gray; dDpMe,
dorsal part of the deep mesencephalic nucleus; DpMe, deep
mesencephalic nucleus; DRN, dorsal raphe nucleus; DTg, dorsal
tegmental nucleus; IP, interpeduncular nucleus; LDTg, latero-
dorsal tegmental nucleus; lPAG, lateral periaqueductal gray; LPB,
lateral parabrachial nucleus; me5, mesencephalic trigeminal tract;
ml, medial lemniscus; mlf, medial longitudinal fasciculus; MnR,
median raphe nucleus; Pn, pontine nuclei; PnO, pontine reticular
nucleus, oral part; PPTg, pedunculopontine tegmental nucleus; py,
pyramidal tract; RR, retrorubral nucleus; scp, superior cerebellar
peduncle; SLD, sublaterodorsal nucleus; vlPAG, ventrolateral
periaqueductal gray; VLL, ventral nucleus of the lateral lemniscus;
VTg, ventral tegmental nucleus.
Found at: doi:10.1371/journal.pone.0004272.s002 (10.14 MB
TIF)
Figure S3 Schematic distribution of Fos+ (small black dots) and
Fos-GAD (large red dots) neurons on coronal sections taken at
600 mm intervals from 29.20 to 210.40 from Bregma in a
representative animal for PSC (left hand side), PSD (middle) and
PSR (right hand side) conditions after Fos immunohistochemistry
combined with GAD67 mRNA in situ hybridization. Abbrevia-
tions: 6, abducens nucleus; 7, facial nucleus; 7n, facial nerve;
CGPn, central gray of the pons; CnF, cuneiform nucleus; g7, genu
of the facial nerve; Gi, gigantocellular reticular nucleus; GiA,
gigantocellular reticular nucleus, alpha part; icp, inferior cerebellar
peduncle; KF, Ko ¨lliker-Fuse nucleus; LC, locus coeruleus; LDTg,
laterodorsal tegmental nucleus; LPB, lateral parabrachial nucleus;
LPGi, lateral paragigantocellular nucleus; me5, mesencephalic
trigeminal tract; mlf, medial longitudinal fasciculus; Mo5, motor
trigeminal nucleus; MVe, medial vestibular nucleus; PCRt,
parvicellular reticular nucleus; Pn, pontine nuclei; PnC, pontine
reticular nucleus, caudal part; PnV, pontine reticular nucleus,
ventral part; Pr, prepositus nucleus; py, pyramidal tract; RMg,
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cerebellar peduncle; SLD, sublaterodorsal nucleus; SO, superior
paraolivary nucleus; Sp5O, spinal trigeminal nucleus, oral part;
sp5, spinal trigeminal tract.
Found at: doi:10.1371/journal.pone.0004272.s003 (9.51 MB TIF)
Figure S4 Schematic distribution of Fos+ (small black dots) and
Fos-GAD (large red dots) neurons on coronal sections taken at
600 mm intervals from 211.00 to 212.80 from Bregma in a
representative animal for PSC (left hand side), PSD (middle) and
PSR (right hand side) conditions after Fos immunohistochemistry
combined with GAD67 mRNA in situ hybridization. Abbrevia-
tions: 7, facial nucleus; 12, hypoglossal nucleus; cDPGi, caudal
part of the dorsal paragigantocellular nucleus; Gi, gigantocellular
reticular nucleus; GiA, gigantocellular reticular nucleus, alpha
part; GiV, gigantocellular reticular nucleus, ventral part; icp,
inferior cerebellar peduncle; IO, inferior olive; LPGi, lateral
paragigantocellular nucleus; mlf, medial longitudinal fasciculus;
MVe, medial vestibular nucleus; PCRt, parvicellular reticular
nucleus; Pr, prepositus nucleus; py, pyramidal tract; rDPGi, rostral
part of the dorsal paragigantocellular nucleus; RMg, raphe
magnus nucleus; ROb, raphe obscurus nucleus; RPa, raphe
pallidus nucleus; Sol, nucleus of the solitary tract; Sp5O, spinal
trigeminal nucleus, oral part; sp5, spinal trigeminal tract.
Found at: doi:10.1371/journal.pone.0004272.s004 (9.31 MB TIF)
Figure S5 Photomicrograph illustrating a representative Pha-
seolus vulgaris leucoagglutinin (PHA-L) injection site in the
vlPAG/dDpMe region used to localize muscimol and saline
injections. Immunohistochemical detection of PHAL was made
with the same sequential protocol described for Fos using a rabbit
primary antibody to PHAL (1:5000; DAKO, Denmark) and a
DAB solution containing 0.6% of nickel ammonium sulphate.
Abbreviations: 4, trochlear nucleus; Aq, Sylvius aqueduct;
dDpMe, dorsal part of the deep mesencephalic nucleus; DpMe,
deep mesencephalic nucleus;DRN, dorsal raphe nucleus; Me5,
mesencephalic trigeminal nucleus; mlf, medial longitudinal
fasciculus; vlPAG, ventrolateral periaqueductal gray. Scale bar:
500 mm.
Found at: doi:10.1371/journal.pone.0004272.s005 (4.64 MB TIF)
Video S1 Video showing the behavior of a head-restrained rat
and the simultaneous EOG, EMG and EEG recording during an
episode of PS occurring after a Mus ejection in the vlPAG/
dDpMe. The rat is immobile and display phasic movements of the
vibrissae. The EOG shows the occurrence of REM, the EMG if
flat and the EEG is activated and display theta activity.
Found at: doi:10.1371/journal.pone.0004272.s006 (8.10 MB AVI)
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